Tarek Sahmoud
Geen lopende functies
Loopbaan van Tarek Sahmoud
Eerdere bekende functies van Tarek Sahmoud
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CONTEXT THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | - | 31-12-2023 |
H3 Biomedicine, Inc.
 H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Hoofd Techniek/Wetenschap/O&O | 01-05-2016 | 01-07-2017 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
| HUMANIGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2018 | - |
Opleiding van Tarek Sahmoud
| KasrAlAiny School of Medicine | Undergraduate Degree |
| Bordeaux Segalen University | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Egypte | 2 |
| Frankrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HUMANIGEN, INC. | Health Technology |
| CONTEXT THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
H3 Biomedicine, Inc.
H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa. | Health Technology |
- Beurs
- Insiders
- Tarek Sahmoud
- Ervaring
